KHN reporter Alvin Tran compiled a selection of recently released health policy studies and briefs.
Health Affairs: The Impact On Hospitals Of Reducing Surgical Complications Suggests Many Will Need Shared Savings Programs With Payers
The authors write: "We found that if a hospital's surgical inpatient volume is not growing, such a program results in negative cash flow. We also found that if a hospital's surgical volume is growing, and if the hospital can sufficiently reduce the average length-of-stay for surgical patients without complications, the cash flow could be positive. We recommend that hospitals with limited growth prospects that are nonetheless contemplating a surgical complication reduction program establish agreements with payers to share in any savings generated by the program" (Krupka, Sandberg and Weeks, 10/17).
Health Affairs/RWJF Health Policy Brief Series: Pay-For-Performance -- The federal health law seeks to use pay-for-performance initiatives to improve the overall quality of care by providing financial incentives to hospitals and health care providers based on optimal performance and efficiency. But the author of this brief on public and private initiatives writes that PFP programs have yielded mixed results, and notes that the "cost of adopting health information technology" and the impact on "poorer and disadvantaged populations" are raising concerns: "Experience to date with pay-for-performance initiatives has raised a number of questions that require more research and experimentation" (James, 10/11).
American Journal Of Public Health: New Jersey's HIV Exposure Law And The HIV-Related Attitudes, Beliefs, And Sexual And Seropositive Status Disclosure Behaviors Of Persons Living With HIV -- While the majority of states have enacted laws to regulate the sexual behavior of people living with HIV, there is still uncertainty as to whether these have been effective. This study surveyed nearly 500 people with HIV to explore the impact of New Jersey's law. Researchers found that just more than half of the participants knew about the state's exposure law, but there was no link between that awareness and sexual abstinence, condom usage with recent partners, or disclosure of participants' positive HIV-status to partners: "Criminalizing nondisclosure of HIV serostatus does not reduce sexual risk behavior. Although the laws do not appear to increase stigma, they are also not likely to reduce HIV transmission" (Galletly et al., 11/2012).
American Journal Of Infection Control: Wide Variation In Adoption Of Screening And Infection Control Interventions For Multidrug-Resistant Organisms: A National Study -- Many of the nation's hospitals have adopted screening and infection control policies for multidrug-resistant organisms (MDROs). In a survey that included 250 hospitals, Columbia University researchers found that these efforts in intensive care units vary widely. For example, only 40 percent of ICUs had a written policy to screen all patients for any MDRO, and only 27 percent had policies requiring periodic screening following admission (Pogorzelska, Stone and Larson, 10/2012).
BMJ Open: Shame! Self-Stigmatization As An Obstacle To Sick Doctors Returning To Work: A Qualitative Study--Doctors hold the responsibility of treating the sick but they, too, can be vulnerable. Researchers did in-depth interviews with 19 doctors from the United Kingdom who had physical or mental health problems or issues pertaining to drug and alcohol abuse and found that many of them had self-stigmatizing views. These negative self-images made it difficult for doctors to return to work. "Doctors must learn to provide themselves and their colleagues with the same level of excellent care that they provide for their patients," the researchers wrote (Henderson et al., 10/15).
Here is a selection of news coverage of other recent research:
Medpage Today: Privacy Key Issue In Genome Decoding
Researchers and clinicians need to develop robust yet understandable informed consent procedures to protect patient wishes after their entire DNA is sequenced, a presidential commission said. As the practice of whole genome sequencing is expanded upon and integrated with clinical medicine, Congress, state governments, and federal agencies need to take greater steps to ensure patients' privacy, the Presidential Commission for the Study of Bioethical Issues recommended. ... Sequencing a single human genome will soon cost less than $1,000 but can tell doctors a patient's predisposition for cancer or Alzheimer's disease, or provide information on which treatment options are best for particular illnesses (Pittman, 10/17).